SWTX:NSD-SpringWorks Therapeutics Inc (USD)

COMMON STOCK | Biotechnology |

Last Closing

USD 36.81

Change

-0.56 (-1.50)%

Market Cap

N/A

Volume

0.29M

Analyst Target

USD 54.40
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
VRTX Vertex Pharmaceuticals Inc

+2.91 (+0.72%)

USD 120.60B
REGN Regeneron Pharmaceuticals Inc

-0.66 (-0.09%)

USD 84.94B
ARGX argenx NV ADR

+1.67 (+0.27%)

USD 36.54B
ALNY Alnylam Pharmaceuticals Inc

+0.99 (+0.41%)

USD 31.66B
BGNE BeiGene Ltd

+3.92 (+2.21%)

USD 20.24B
UTHR United Therapeutics Corporatio..

-2.78 (-0.76%)

USD 16.18B
MRNA Moderna Inc

+0.68 (+1.72%)

USD 16.10B
RPRX Royalty Pharma Plc

-0.02 (-0.08%)

USD 15.27B
SMMT Summit Therapeutics PLC

+0.33 (+1.77%)

USD 13.67B
INCY Incyte Corporation

+0.07 (+0.10%)

USD 13.52B

ETFs Containing SWTX

CEW:CA iShares Equal Weight Banc.. 10.23 % 0.60 %

+0.04 (+0.00%)

CAD 0.24B
HFIN:CA Hamilton Enhanced Canadia.. 10.20 % 0.00 %

N/A

CAD 0.20B
FLI:CA CI U.S. & Canada Lifeco C.. 9.76 % 0.92 %

-0.12 (0.00%)

CAD 0.09B
HEF:CA 7.65 % 0.83 %

N/A

N/A
TQCD:CA TD Q Canadian Dividend ET.. 3.88 % 0.00 %

+0.01 (+0.00%)

CAD 0.38B
FIE:CA iShares Canadian Financia.. 3.87 % 0.97 %

+0.02 (+0.00%)

CAD 1.09B
HLIF:CA Harvest Canadian Equity I.. 3.45 % 0.00 %

+0.06 (+0.00%)

CAD 0.12B
XMV:CA iShares MSCI Canada Minim.. 2.95 % 0.33 %

+0.16 (+0.00%)

CAD 0.25B
TLV:CA Invesco S&P/TSX Composite.. 2.35 % 0.34 %

+0.11 (+0.00%)

CAD 0.07B
FICS First Trust International.. 2.21 % 0.00 %

+0.14 (+0.00%)

USD 0.16B
XMD:CA iShares S&P/TSX Completio.. 1.94 % 0.61 %

+0.16 (+0.00%)

CAD 0.23B
HPR:CA Global X Active Preferred.. 1.92 % 0.63 %

+0.03 (+0.00%)

CAD 1.04B
CNCR Loncar Cancer Immunothera.. 0.00 % 0.79 %

+0.03 (+0.00%)

USD 0.01B
DXM:CA 0.00 % 0.67 %

N/A

N/A
PR:CA Lysander-Slater Preferred.. 0.00 % 1.03 %

-0.01 (0.00%)

CAD 0.08B
RODM Hartford Multifactor Deve.. 0.00 % 0.31 %

+0.12 (+0.00%)

N/A
BANK:CA Evolve Canadian Banks and.. 0.00 % 0.39 %

N/A

CAD 0.33B
BNC:CA Purpose Canadian Financia.. 0.00 % 0.68 %

+0.14 (+0.00%)

N/A
TPIF Timothy Plan Internationa.. 0.00 % 0.00 %

+0.10 (+0.00%)

USD 0.11B

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.85% 67% D+ 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.85% 67% D+ 47% F
Trailing 12 Months  
Capital Gain 1.71% 67% D+ 53% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.71% 66% D+ 49% F
Trailing 5 Years  
Capital Gain -6.86% 75% C 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.86% 75% C 41% F
Average Annual (5 Year Horizon)  
Capital Gain 18.22% 64% D 72% C
Dividend Return 18.22% 64% D 71% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 65.45% 54% F 30% F
Risk Adjusted Return 27.84% 82% B 60% D-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector